Search | IOVS | ARVO Journals

Showing 1 – 19 of 19

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract July 2019

Fluorescence Imaging of Biofilm on Eyelashes

Michael Bahren Choi; Donna B Stolz; Eric D Donnenfeld; Henry D Perry

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):831.

ARVO Annual Meeting Abstract July 2019

Differential bacterial colonization and biofilm formation on punctal occluders in vitro.

Lola Grillo; Michael Hadjiargyrou; Eric D Donnenfeld; Henry D Perry

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):4170.

ARVO Annual Meeting Abstract June 2017

Endothelial Corneal Dystrophy Associated with A3243G Mitochondrial DNA Point Mutation

Mathieu F Bakhoum; Eugenia C White; Wei-Pu Wu; Jesse D Sengillo; Gregory D Kramer; Henry D Perry; Stephen H Tsang

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):5649.

ARVO Annual Meeting Abstract March 2012

Astigmatism Correction Post Penetrating Keratoplasty (PK) Using a Femtosecond Laser System (LensX)

Nicholas Nissirios; Henry D. Perry; Eric Donnenfeld; Erfan Nadji

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):1503.

ARVO Annual Meeting Abstract April 2011

Xalatan® (latanoprost) is Better Tolerated than Travatan Z® (travoprost) in Ocular Hypertensive or Glaucoma Patients with Mild to Moderate Dry Eye

Marguerite B. McDonald; Stanley J. Berke; Eric D. Donnenfeld; Russell Fumuso; Ronald M. Caronia; Gerard D'Aversa; Henry D. Perry; Paul R. Galstian; Raymond E. Mariani; Richard T. Sturm

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):3840.

ARVO Annual Meeting Abstract April 2011

Real Time Intraoperative Wavefront Aberrometry To Refine Outcomes In Patients With Long Or Short Axial Lengths Undergoing Cataract Surgery

Allon Barsam; Henry D. Perry; Eric D. Donnenfeld

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):5699.

ARVO Annual Meeting Abstract April 2011

An Investigation of the Safety and Efficacy Of Subconjunctival Bevacizumab in the Treatment of Corneal Neovascularization

Nicholas Nissirios; Renee Solomon; Allon Barsam; Jay Fiore; Zac Davis; Alicia Perry; Marcelle Morcos; Eric D. Donnenfeld; Henry D. Perry

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):6384.

ARVO Annual Meeting Abstract April 2009

Effects of Xalatan® (Latanoprost Ophthalmic Solution) or Travatan Z® (Travoprost Ophthalmic Solution) on Ocular Surface Signs and Symptoms in Ocular Hypertensive or Glaucoma Patients: An Exploratory Study

M. B. McDonald; E. D. Donnenfeld; H. D. Perry; G. D'Aversa; M. A. Swerdin; D. M. Sachs; J. R. Wittpenn, Jr.; J. K. Oats; R. E. Mariani; P. R. Galstian

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):4652.

ARVO Annual Meeting Abstract April 2009

Prospective Investigation of Intravitreal Injection Needles Cultured Immediately Following Injection of Corticosteroids, AvastinR or Lucentis R

H. D. Perry; G. S. Stoller; K. B. Carnevale; S. McCormick; M. Shah; S. A. Berger; E. D. Donnenfeld

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):5021.

ARVO Annual Meeting Abstract May 2008

Comparison of Topography-Guided Lasik (tgl) to Standard Lasik (sl) for Hyperopia: Is It Important to Adjust for Angle Kappa?

J. N. Nam; G. Pamel; A. J. Kanellopoulos; H. D. Perry

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):3356.

ARVO Annual Meeting Abstract May 2008

Argon Laser Iridoplasty to Improve Visual Function Following Multifocal IOL Implantation

R. Solomon; E. D. Donnenfeld; H. D. Perry; J. Stein; J. Holladay

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):1035.

ARVO Annual Meeting Abstract May 2007

The Effect of Decreasing Cyclosporine 0.05% on Dry Eye Disease After One Year of Therapy

M. Y. Su; H. D. Perry; E. D. Donnenfeld; J. R. Wittpenn

Invest. Ophthalmol. Vis. Sci.. 2007; 48(13):374.

ARVO Annual Meeting Abstract May 2007

Anesthesia and Ocular Tolerability of Topical Non-Steroidal Anti-Inflammatory Drugs: A Direct Comparison Between Ketorolac and Bromfenac

T. Y. Chou; H. D. Perry; P. J. G. Maris, Jr.; E. D. Donnenfeld; M. Su

Invest. Ophthalmol. Vis. Sci.. 2007; 48(13):4269.

ARVO Annual Meeting Abstract May 2007

Ahmed Glaucoma Implant for Control of Refractory Glaucoma Following Penetrating Keratoplasty. A Challenging Management Venue

N. M. Radcliffe; H. D. Perry; A. J. Kanellopoulos

Invest. Ophthalmol. Vis. Sci.. 2007; 48(13):4671.

Articles October 1990

Transscleral microwave cyclodestruction.

PDF

P T Finger; P D Smith; R W Paglione; H D Perry
TAGS: microwaves
Invest. Ophthalmol. Vis. Sci.. 1990; 31(10):2151-2155.

Articles September 1990

Intraocular radiation blocking.

PDF

P T Finger; T K Ho; D M Fastenberg; R A Hyman; E M Stroh; S Packer; H D Perry
TAGS: radiation
Invest. Ophthalmol. Vis. Sci.. 1990; 31(9):1724-1730.

Articles August 1989

Hyperthermic treatment of rabbit corneas.

PDF

W S Goldblatt; P T Finger; H D Perry; E M Stroh; D S Weiser; E D Donnenfeld
TAGS: cornea, hyperthermia, oryctolagus cuniculus
Invest. Ophthalmol. Vis. Sci.. 1989; 30(8):1778-1783.

Articles October 1979

Sustained release of BCNU for the treatment of intraocular malignancies in animal models.

PDF

H S Liu; M F Refojo; H D Perry; D M Albert
TAGS: animal model, cancer, carmustine
Invest. Ophthalmol. Vis. Sci.. 1979; 18(10):1061-1067.

Articles October 1978

Direct delivery of anticancer agents: experimental treatment of intraocular malignancy.

PDF

H S Liu; M F Refojo; H D Perry; D M Albert
TAGS: antineoplastic agents, cancer, experimental treatment
Invest. Ophthalmol. Vis. Sci.. 1978; 17(10):993-1004.

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Fluorescence Imaging of Biofilm on Eyelashes

Differential bacterial colonization and biofilm formation on punctal occluders in vitro.

Endothelial Corneal Dystrophy Associated with A3243G Mitochondrial DNA Point Mutation

Astigmatism Correction Post Penetrating Keratoplasty (PK) Using a Femtosecond Laser System (LensX)

Xalatan® (latanoprost) is Better Tolerated than Travatan Z® (travoprost) in Ocular Hypertensive or Glaucoma Patients with Mild to Moderate Dry Eye

Real Time Intraoperative Wavefront Aberrometry To Refine Outcomes In Patients With Long Or Short Axial Lengths Undergoing Cataract Surgery

An Investigation of the Safety and Efficacy Of Subconjunctival Bevacizumab in the Treatment of Corneal Neovascularization

Effects of Xalatan® (Latanoprost Ophthalmic Solution) or Travatan Z® (Travoprost Ophthalmic Solution) on Ocular Surface Signs and Symptoms in Ocular Hypertensive or Glaucoma Patients: An Exploratory Study

Prospective Investigation of Intravitreal Injection Needles Cultured Immediately Following Injection of Corticosteroids, AvastinR or Lucentis R

Comparison of Topography-Guided Lasik (tgl) to Standard Lasik (sl) for Hyperopia: Is It Important to Adjust for Angle Kappa?

Argon Laser Iridoplasty to Improve Visual Function Following Multifocal IOL Implantation

The Effect of Decreasing Cyclosporine 0.05% on Dry Eye Disease After One Year of Therapy

Anesthesia and Ocular Tolerability of Topical Non-Steroidal Anti-Inflammatory Drugs: A Direct Comparison Between Ketorolac and Bromfenac

Ahmed Glaucoma Implant for Control of Refractory Glaucoma Following Penetrating Keratoplasty. A Challenging Management Venue

Transscleral microwave cyclodestruction.

Intraocular radiation blocking.

Hyperthermic treatment of rabbit corneas.

Sustained release of BCNU for the treatment of intraocular malignancies in animal models.

Direct delivery of anticancer agents: experimental treatment of intraocular malignancy.

To View More...

You must be signed into an individual account to use this feature.